Literature DB >> 19949783

Urinary obstruction depresses erythropoiesis which recovers after parenchyma-saving surgery but not SWL.

Davor Eterović1, Marijan Situm, Ante Punda, Vinko Marković, Slaven Kokić.   

Abstract

We tested the hypotheses that chronic human urinary obstruction impairs the renal regulation of the red blood cell (RBC) production and compared the chronic outcome of relief of obstruction between parenchyma-saving surgery and extracorporeal lithotripsy (SWL). We measured RBC count and serum erythropoietin (Epo) concentration before and 3 months after relief of urinary obstruction in 60 patients treated with pyelolithotomy, ureterolithotomy or ureteroscopy and in 62 patients treated with SWL. Compared with 333 healthy controls, at baseline, patients scheduled for parenchyma-saving surgery had lowered RBC count [9.9% (6.9-13.1); 95% confidence interval] in case of males and 17.7% (14.2-21.4) in case of females; minor depression in RBC count was also observed in female patients scheduled for SWL. Epo serum levels were mildly reduced in SWL patients and halved in parenchyma-saving surgery group. At 3 months following relief of obstruction in 50 operated patients without recurrent or residual stone, Epo levels almost doubled, becoming normal, while RBC count and haemoglobin concentration increased for 6.1% (3.8-8.8) and 8.8% (6.1-10.6). In contrast, in 49 SWL patients only minor, bidirectional responses to treatment were observed. We conclude that obstructive uropathy is associated with clinically relevant effects on erythropoiesis, which is reversed after relief of obstruction by parenchyma-saving surgery that saves the renal parenchyma.

Entities:  

Mesh:

Year:  2009        PMID: 19949783     DOI: 10.1007/s00240-009-0234-0

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  22 in total

Review 1.  Sites of erythropoietin production.

Authors:  P H Maxwell; D J Ferguson; L G Nicholls; J P Iredale; C W Pugh; M H Johnson; P J Ratcliffe
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

2.  Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.

Authors:  M Chandra; G K Clemons; M I McVicar
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

3.  Radionuclide evaluation pre- and postextracorporeal shock wave lithotripsy for renal calculi.

Authors:  J Bomanji; S A Boddy; K E Britton; C C Nimmon; H N Whitfield
Journal:  J Nucl Med       Date:  1987-08       Impact factor: 10.057

4.  Lowered plasma erythropoietin in hypoxic rats with kidney tubule lesions.

Authors:  W Jelkmann; N Marienhoff; S Giesselmann; L Busch
Journal:  Blut       Date:  1988-11

5.  Transient suppression of erythropoietin synthesis in hydronephrosis.

Authors:  Y Tsukada; N Murata; S Yano; T Naruse
Journal:  Nephron       Date:  1994       Impact factor: 2.847

6.  Dose-dependent effect of angiotensin II on human erythropoietin production.

Authors:  S M Freudenthaler; I Lucht; T Schenk; M Brink; C H Gleiter
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

7.  Erythropoietin production in rats with post-ischemic acute renal failure.

Authors:  C C Tan; L H Tan; K U Eckardt
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

8.  Ureter obliteration transiently depresses erythropoietin production.

Authors:  E Necas; P Ponka
Journal:  Eur J Clin Invest       Date:  1998-11       Impact factor: 4.686

Review 9.  Molecular biology of erythropoietin.

Authors:  Wolfgang Jelkmann
Journal:  Intern Med       Date:  2004-08       Impact factor: 1.271

Review 10.  Erythropoietin: physiology and pharmacology update.

Authors:  James W Fisher
Journal:  Exp Biol Med (Maywood)       Date:  2003-01
View more
  1 in total

1.  Wrong perspective obscures the adverse effects of shock-wave lithotripsy.

Authors:  Davor Eterović; Marijan Situm; Vinko Marković; Ante Punda
Journal:  Urolithiasis       Date:  2012-12-23       Impact factor: 3.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.